Pirfenidone in restrictive allograft syndrome after lung transplantation: A case series
Sign Up to like & getrecommendations! Published in 2018 at "American Journal of Transplantation"
DOI: 10.1111/ajt.15019
Abstract: Pirfenidone may attenuate the decline of pulmonary function in restrictive allograft syndrome (RAS) after lung transplantation. We retrospectively assessed all lung transplant recipients with RAS who were treated with pirfenidone for at least 3 months… read more here.
Keywords: lung transplantation; lung; allograft syndrome; pirfenidone ... See more keywords